On January 5, 2012, Covidien, a leading global healthcare products company, acquired BÂRRX Medical, Inc.
Because of the increase of gastroesophageal reflux disease and subsequent increase in diagnoses of Barrett’s esophagus, it has become a popular news segment both in print and broadcast media. Watch, listen or read the latest about Barrett’s esophagus and a safe, effective treatment therapy called radiofrequency ablation.
During our recent roundtable meeting of gastroenterologists who specialize in Barrett's esophagus diagnosis and treatment, 100% of attendees responded that consumer education programs about Barrett’s esophagus and its possible progression have the potential of saving lives. This belief in the value of education and early intervention is the basis for Covidien’s integrated campaign to reach U.S. consumers.